Soleus Capital Management, L.P.

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in EWTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$45,672,322

+$23,090,672 QoQ

Shares Held

1,449,915

+59.3% QoQ

Ownership

1.35%

of shares outstanding

% of Portfolio

1.85%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,377,926,099 across 59 Biotechnology names. EWTX ranks #7 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc.	330,517	$106,489,272
5	VCEL	Vericel Corp	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	EWTX	Edgewise Therapeutics, Inc. This page	1,449,915	$45,672,322
8	ALNY	Alnylam Pharmaceuticals, Inc.	131,650	$43,559,035

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,672,322	1,449,915	+59.3%	Shares	Sole	2026-05-14
2025-12-31	$22,581,650	910,000	+1089.7%	Shares	Sole	2026-02-12
2025-06-30	$1,002,823	76,493	+5.8%	Shares	Sole	2025-08-15
2025-03-31	$1,590,600	72,300	-60.6%	Shares	Sole	2025-05-15
2024-12-31	$4,894,110	183,300	+485.6%	Shares	Sole	2025-02-14
2021-09-30	$519,580	31,300	0.0%	Shares	Sole	2021-11-15
2021-06-30	$667,629	31,300	-68.7%	Shares	Sole	2021-08-16
2021-03-31	$3,250,000	100,000	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.